Uphealth Analysis

Uphealth Stock Analysis Notes

About 47.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.07. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Uphealth recorded a loss per share of 4.5. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 9th of December 2022. UpHealth, Inc. operates as a digital health services company. The companys solutions include Syntranet Core Platform, an integrated care management platform Cloudbreak, a provider of unified telemedicine solutions and digital health tools HelloLyf from Glocal, a platform that delivers primary care and specialty consultations and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. Uphealth operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 882 people. For more information please call Ramesh Balakrishnan at 312 618 1322 or visit https://uphealthinc.com.

Uphealth Investment Alerts

Uphealth Upcoming and Recent Events

Uphealth Market Capitalization

The company currently falls under 'Nano-Cap' category with a total capitalization of 5.33 M.

Uphealth Profitablity

The company has Net Profit Margin of (0.49) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.05 %, which entails that for every 100 dollars of revenue, it generated $0.05 of operating income.

Uphealth Insider Trading Activities

Uphealth Outstanding Bonds

Stock analysis is the technique used by a trader or investor to examine and evaluate how Uphealth prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Uphealth shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Uphealth. By using and applying Uphealth Stock analysis, traders can create a robust methodology for identifying Uphealth entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

If you are still planning to invest in Uphealth check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Uphealth's history and understand the potential risks before investing.